Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maine Proposes Reporting Priority For Phthalates In Some Children’s Products

This article was originally published in The Tan Sheet

Executive Summary

The Clean and Healthy Maine group asks the state’s Department of the Environment to add four phthalates to its list of priority chemicals, requiring firms to report their use in certain children’s personal care products and other product categories.

You may also be interested in...



ACSH Implicates Industry, Retailers In Phthalates Scaremongering

The American Council on Science and Health includes phthalates in its list of 2013’s top “unfounded health scares” and suggests that by bowing to NGO pressure and discontinuing use of the ingredients, manufacturers and retailers are contributing to phthalates “hysteria.”

In Brief: Clearblue estimates weeks, Barry Meltzer dies, P&G eliminating phthalates and triclosan, NPLEx adds Delaware

P&G Clearblue pregnancy test estimates week of conception; AHPA co-founder Meltzer dies; P&G to eliminate phthalates, triclosan; CSPI, Aloe Science Council square off; Delaware joins NPLEx; IADSA focuses on supplement safety guidelines; Pharmavite expands Alabama facility.

IFRA Implements New Methodology With 49th Amendment To Fragrance Safety Standards

The International Fragrance Association has given its ingredient safety standards a major overhaul based on a new methodology that accounts for aggregate exposure and an updated Quantitative Risk Assessment model for dermal sensitization.

Topics

Related Companies

UsernamePublicRestriction

Register

PS107062

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel